| Title: |
LBA2 First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC: Safety, pharmacokinetics (PK) and immunogenicity in CASPIAN |
| Authors: |
Özgüroğlu, M.; Goldman, J.W.; Reinmuth, N.; Chen, Y.; Dvorkin, M.; Trukhin, D.; Statsenko, G.; Hotta, K.; Ji, J.H.; Hochmair, M.J.; Voitko, O.; Havel, L.; Poltoratskiy, A.; Losonczy, G.; Verderame, F.; Thomas, M.; Zheng, Y.; Lloyd, A.; Jiang, H.; Paz-Ares, L. |
| Source: |
Annals of Oncology ; volume 30, page xi66 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2019 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/annonc/mdz453.003 |
| Availability: |
http://dx.doi.org/10.1093/annonc/mdz453.003; https://api.elsevier.com/content/article/PII:S0923753420345518?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753420345518?httpAccept=text/plain; http://academic.oup.com/annonc/article-pdf/30/Supplement_11/mdz453.003/31508150/mdz453.003.pdf |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.D33CCD12 |
| Database: |
BASE |